Skip to content

Carter Bankshares, Inc. CARE Restricted stock acquisition consideration

Restricted stock acquisition consideration at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
$7.71M+53,067%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0
Radiant Logistics logo
Radiant LogisticsRLGT
$16K
Blackbaud logo
BlackbaudBLKB
$2K+100%
HWK
HawkinsHWKN
$0
Lincoln Educational Services Corporation logo
Lincoln Educational Services CorporationLINC
$1.44M+19.8%

Other financials

Income statement

See full
Revenue$106.9M+189%
Net income$85.8M+858%
EPS (diluted)$3.88+895%

Balance sheet

See full
Cash & equivalents$65.7M-70.9%
Total debt$10.9M+5.0%
Total equity$504.9M+25.7%
Total assets$4.8B+2.1%

Cash flow

See full
Operating cash flow$303.9M+4,667%
CapEx$1.5M+0.9%
Free cash flow$302.4M+6,131%

Valuation

See full
Market cap$726.22M+90.6%
P/E6.7×-7.1×
P/S3.3×+0.5×

Profitability

See full
Net margin48.5%+28.6pp
FCF margin147.6%

Returns & leverage

See full
Return on equity23.9%+16.6pp
Debt / equity0.0×

Where this comes from

Reported directly by Carter Bankshares, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross.

The official record: Carter Bankshares, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Carter Bankshares, Inc.'s restricted stock acquisition consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Carter Bankshares, Inc.'s restricted stock acquisition consideration?
Carter Bankshares, Inc. (CARE) reported restricted stock acquisition consideration of $0 in Q1 2026.